Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, pharmacokinetics, and pharmacodynamics of MEDI5884 in adults with stable coronary heart disease has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Heart Disease

Drugs mentioned

• MEDI5884

Snippet

Sponsor: MedImmune LLC | Conditions: Stable Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-12-19